FGFR4 and adenocarcinoma: To test the in vivo tumorigenic effects of the FGFR4-388Arg variant, we xenografted into nude mice the adenocarcinoma cell line H2009 and the squamous cell carcinoma cell line H226 overexpressing either FGFR4 variant.